000 | 01494 a2200397 4500 | ||
---|---|---|---|
005 | 20250513083306.0 | ||
264 | 0 | _c19960119 | |
008 | 199601s 0 0 eng d | ||
022 | _a0277-3732 | ||
024 | 7 |
_a10.1097/00000421-199512000-00009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIngle, J N | |
245 | 0 | 0 |
_aEvaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer. _h[electronic resource] |
260 |
_bAmerican journal of clinical oncology _cDec 1995 |
||
300 |
_a498-501 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCystitis _xchemically induced |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
650 | 0 | 4 |
_aMesna _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aRemission Induction |
700 | 1 | _aKrook, J E | |
700 | 1 | _aMailliard, J A | |
700 | 1 | _aHartmann, L C | |
700 | 1 | _aWieand, H S | |
773 | 0 |
_tAmerican journal of clinical oncology _gvol. 18 _gno. 6 _gp. 498-501 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199512000-00009 _zAvailable from publisher's website |
999 |
_c8525300 _d8525300 |